Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C A de Jager

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Thrombosis and Haemostasis|October 21, 2011
Vaccination strategies in atherosclerosisS C A de Jager, J Kuiper
Mediators of Inflammation|January 7, 2014
Mesenchymal stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptorsF van den Akker, S C A de Jager, J P G Sluijter
Vascular Pharmacology|February 23, 2018
The morphological and molecular mechanisms of epithelial/endothelial-to-mesenchymal transition and its involvement in atherosclerosisM Wesseling, T R Sakkers, S C A de Jager, et al.
Current Pharmaceutical Design|April 14, 2007
Chemokines and atherosclerotic plaque progression: towards therapeutic targeting?A O Kraaijeveld, S C A de Jager, T J C van Berkel, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 5, 2002
Hypersensitivity reactions in mouse airways after a single and a repeated hapten challengeA H van Houwelingen, S C A de Jager, M Kool, et al.
Circulation|October 3, 2007
CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptomsA O Kraaijeveld, S C A de Jager, W J de Jager, et al.
Journal of Internal Medicine|February 26, 2016
Heat-killed Staphylococcus aureus reduces atherosclerosis by inducing anti-inflammatory macrophagesV Frodermann, J van Duijn, G H M van Puijvelde, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 12, 2013
An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activationJ C Karper, S C A de Jager, M M Ewing, et al.
Cardiovascular Diabetology|May 13, 2022
Increased frequency of proangiogenic tunica intima endothelial kinase 2 (Tie2) expressing monocytes in individuals with type 2 diabetes mellitusM Reijrink, J van Ark, C P H Lexis, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 11, 2024
Cardiac delivery of modified mRNA using lipid nanoparticles: Cellular targets and biodistribution after intramyocardial administrationM C I Labonia, M Estapé Senti, P H van der Kraak, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Thrombosis and Haemostasis|October 21, 2011
Vaccination strategies in atherosclerosisS C A de Jager, J Kuiper
Mediators of Inflammation|January 7, 2014
Mesenchymal stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptorsF van den Akker, S C A de Jager, J P G Sluijter
Vascular Pharmacology|February 23, 2018
The morphological and molecular mechanisms of epithelial/endothelial-to-mesenchymal transition and its involvement in atherosclerosisM Wesseling, T R Sakkers, S C A de Jager, et al.
Current Pharmaceutical Design|April 14, 2007
Chemokines and atherosclerotic plaque progression: towards therapeutic targeting?A O Kraaijeveld, S C A de Jager, T J C van Berkel, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 5, 2002
Hypersensitivity reactions in mouse airways after a single and a repeated hapten challengeA H van Houwelingen, S C A de Jager, M Kool, et al.
Circulation|October 3, 2007
CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptomsA O Kraaijeveld, S C A de Jager, W J de Jager, et al.
Journal of Internal Medicine|February 26, 2016
Heat-killed Staphylococcus aureus reduces atherosclerosis by inducing anti-inflammatory macrophagesV Frodermann, J van Duijn, G H M van Puijvelde, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 12, 2013
An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activationJ C Karper, S C A de Jager, M M Ewing, et al.
Cardiovascular Diabetology|May 13, 2022
Increased frequency of proangiogenic tunica intima endothelial kinase 2 (Tie2) expressing monocytes in individuals with type 2 diabetes mellitusM Reijrink, J van Ark, C P H Lexis, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 11, 2024
Cardiac delivery of modified mRNA using lipid nanoparticles: Cellular targets and biodistribution after intramyocardial administrationM C I Labonia, M Estapé Senti, P H van der Kraak, et al.
Pageof 2